UBS Group’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.31M | Sell |
|
|||||
|
2025
Q2 | $4.37M | Buy |
|
|||||
|
2025
Q1 | $2.58M | Buy |
|
|||||
|
2024
Q4 | $2.23M | Buy |
|
|||||
|
2024
Q3 | $579K | Sell |
|
|||||
|
2024
Q2 | $595K | Buy |
|
|||||
|
2024
Q1 | $412K | Sell |
|
|||||
|
2023
Q4 | $704K | Buy |
|
|||||
|
2023
Q3 | $108K | Sell |
|
|||||
|
2023
Q2 | $464K | Buy |
|
|||||
|
2023
Q1 | $67.2K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $22K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $27K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $56K | Buy |
|